| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.00067 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |